Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have earned a consensus rating of “Buy” from the ten brokerages that are covering the company, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the […]
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned a consensus rating of “Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have covered the stock in the last year is […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report)’s stock price dropped 2.6% on Tuesday . The stock traded as low as $24.24 and last traded at $24.24. Approximately 37,306 shares changed hands during trading, a decline of 97% from the average daily volume of 1,348,370 shares. The stock had previously closed at $24.88. Analyst Ratings […]
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price decreased by Citigroup from $89.00 to $84.00 in a report issued on Thursday morning, Benzinga reports. Citigroup currently has a buy rating on the stock. Several other research firms have also recently weighed in on CRSP. TheStreet upgraded shares of CRISPR Therapeutics from a d+ […]
Kyverna Therapeutics (NASDAQ:KYTX) Reaches New 12-Month Low at $12 16 modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.